TFDA Approves the First Autonomous Neurosurgical Navigation Robot, NaoTrac, from Brain Navi Biotechnology

/PRNewswire/ -- NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from Taiwan's Food and Drug Administration (TFDA) in July 2022, and...

Related Keywords

Taiwan ,Hualien ,Hualian Xian ,Washington ,United States ,San Francisco ,California ,Taiwanese ,Acta Neurochirurgica ,Prnewswire Naotrac ,Surface Mapping Technology ,Hualien Tzu Chi Medical Center ,Brain Navi Biotechnology Co Ltd ,Registration Technology ,Drug Administration ,External Ventricular Drain ,Surface Mapping Auto Registration Technology ,Taiwan Expo United States ,Navi Biotechnology ,Brain Navi Biotechnology Co ,Td ,